ALTRIA GROUP, INC. Annual Report, Year Ended Dec 31, 2018

Altria Group, Inc. reported net revenues of $25.36 billion for the year ended December 31, 2018, a slight decrease from the prior year, primarily driven by lower net revenues in the smokeable products segment, partially offset by higher net revenues in the smokeless products segment. The company's net earnings attributable to Altria decreased significantly to $6.96 billion from $10.22 billion in the prior year, largely due to a higher effective income tax rate resulting from the Tax Reform Act, lower operating income, and a large gain on the AB InBev transaction in the prior year. The company made significant strategic investments in 2018, notably a $12.8 billion investment in JUUL Labs, Inc., representing a 35% economic interest, and announced an agreement to acquire a 45% equity interest in Cronos Group Inc., a cannabinoid company. Despite the overall revenue dip, Altria demonstrated pricing power across its segments, with higher pricing helping to offset lower shipment volumes. The company also announced a cost reduction program expected to yield $575 million in annualized savings by the end of 2019. The report highlights ongoing challenges, including declining cigarette volumes, regulatory scrutiny from the FDA, and litigation risks. However, strategic investments in newer product categories like e-vapor and cannabis signal a forward-looking approach to adapt to evolving consumer preferences and market trends.